These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33176482)

  • 21. Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants.
    Mao QY; Liao XY; Yu X; Li N; Zhu FC; Zeng Y; Liang ZL; Li FX; Wang JZ; Lu FM; Zhuang H
    Chin Med J (Engl); 2010 Jul; 123(13):1679-84. PubMed ID: 20819628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro.
    Wang HQ; Meng S; Li ZR; Peng ZG; Han YX; Guo SS; Cui XL; Li YH; Jiang JD
    J Asian Nat Prod Res; 2013; 15(4):382-9. PubMed ID: 23464760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential.
    Zhou B; Xu L; Zhu R; Tang J; Wu Y; Su R; Yin Z; Liu D; Jiang Y; Wen C; You M; Dai L; Lin Y; Chen Y; Yang H; An Z; Fan C; Cheng T; Luo W; Xia N
    Antiviral Res; 2019 Jan; 161():28-35. PubMed ID: 30419253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
    Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
    Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparisons of epidemiological and clinical characteristics in children with hand-foot-mouth disease caused by Enterovirus 71 and Coxackievirus A16].
    Jia L; Zhao CS; Zhang L; Li S; Zhang DT; Liu BW; Wang QY; Li XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):635-7. PubMed ID: 21849112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro.
    Yeo SG; Song JH; Hong EH; Lee BR; Kwon YS; Chang SY; Kim SH; Lee SW; Park JH; Ko HJ
    Arch Pharm Res; 2015 Feb; 38(2):193-202. PubMed ID: 24752860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
    Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
    J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
    Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro antiviral activity of doxepin hydrochloride against group B coxsackievirus.
    Yang Y; Liu G; Jia J; Zhong J; Yan R; Lin X; Zheng K; Zhu Q
    Virus Res; 2022 Aug; 317():198816. PubMed ID: 35598772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Evaluation of Novel Enterovirus 71 Inhibitors as Therapeutic Drug Leads for the Treatment of Human Hand, Foot, and Mouth Disease.
    Zhang M; Wang Y; He W; Sun Y; Guo Y; Zhong W; Gao Q; Liao M; Wang X; Cai Y; Guo Y; Rao Z
    J Med Chem; 2020 Feb; 63(3):1233-1244. PubMed ID: 31939669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000-2017.
    Noisumdaeng P; Korkusol A; Prasertsopon J; Sangsiriwut K; Chokephaibulkit K; Mungaomklang A; Thitithanyanont A; Buathong R; Guntapong R; Puthavathana P
    Int J Infect Dis; 2019 Mar; 80():84-91. PubMed ID: 30639624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effects of Retro-2
    Dai W; Wu Y; Bi J; Lu X; Hou A; Zhou Y; Sun B; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
    Antiviral Res; 2017 Aug; 144():311-321. PubMed ID: 28688753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applicability of duplex real time and lateral flow strip reverse-transcription recombinase aided amplification assays for the detection of Enterovirus 71 and Coxsackievirus A16.
    Li XN; Shen XX; Li MH; Qi JJ; Wang RH; Duan QX; Zhang RQ; Fan T; Bai XD; Fan GH; Xie Y; Ma XJ
    Virol J; 2019 Dec; 16(1):166. PubMed ID: 31888694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011-2013.
    Fonseca MC; Sarmiento L; Resik S; Martínez Y; Hung LH; Morier L; Piñón A; Valdéz O; Kourí V; González G
    Arch Virol; 2014 Sep; 159(9):2451-5. PubMed ID: 24719197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of antibodies to enterovirus 71 and coxsackievirus A16 among people of various age groups in a northeast province of Thailand.
    Lerdsamran H; Prasertsopon J; Mungaomklang A; Klinmalai C; Noisumdaeng P; Sangsiriwut K; Tassaneetrithep B; Guntapong R; Iamsirithaworn S; Puthavathana P
    Virol J; 2018 Oct; 15(1):158. PubMed ID: 30326914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: A molecular dynamics study.
    Jetsadawisut W; Nutho B; Meeprasert A; Rungrotmongkol T; Kungwan N; Wolschann P; Hannongbua S
    Biophys Chem; 2016 Dec; 219():9-16. PubMed ID: 27668727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cholinesterase: a potential assistant biomarker for hand, foot, and mouth disease caused by enterovirus 71 infection.
    Cheng BN; Jin YL; Chen BQ; Zhu LY; Xu ZC; Shen T
    Infect Dis Poverty; 2016 Mar; 5():27. PubMed ID: 27025584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an Enterovirus 71 Vaccine Efficacy Test Using Human Scavenger Receptor B2 Transgenic Mice.
    Imura A; Sudaka Y; Takashino A; Tamura K; Kobayashi K; Nagata N; Nishimura H; Mizuta K; Koike S
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31896594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.